pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,694 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 213 pdufa · 172 phase 2 completion · 73 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 14 catalysts2026-07-23: 2 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: filing×type: approval×type: phase readout×clear all
type
  • phase readout4,686
  • 8k filing2,347
  • earnings285
  • pdufa213
  • phase 2 completion172
  • phase 1 completion73
phase 2 initiation
62
  • phase 1 initiation40
  • phase 1 2 completion35
  • phase 0 trial completion23
  • therapy area
    • Ophthalmology5

    Date TBD

    50
    ›RECRUITINGphase readoutNCT07567170: Satisfaction of Specific Modes Related to Physical Activity in People Living With Type 1 Diabetes and Using an Hybrid Closed-loop System

    Sponsor: University Hospital, Grenoble. Phase: NA. Conditions: Diabetes

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02710370: Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans

    Sponsor: University of Pittsburgh. Phase: . Conditions: Obesity, Diabetes Mellitus, Type 2, Endocrine System Diseases, Glucose Metabolism Disorders, Metabolic Diseases

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07398573: Comparison of Caudal and Quadratus Lumborum Blocks With Pain Monitoring in Children

    Sponsor: Ankara Etlik City Hospital. Phase: . Conditions: Regional Anesthesia Success, Pain Monitor During Anesthesia, Quadratus Lumborum Nerve Block, Caudal Block for Postoperative Analgesia, Pediatric Anesthesia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06570369: A Study to Explore the Effect of SP-624 on Brain Network Analytics in Healthy Adults and Adults With Major Depression

    Sponsor: Sirtsei Pharmaceuticals, Inc.. Phase: PHASE1. Conditions: Major Depressive Disorder, Depression, Healthy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04733469: EMPOWER 3: Improving Palliative Care Health Literacy and Utilization

    Sponsor: Tulane University. Phase: NA. Conditions: Cancer, Neoplasm Malignant

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07636369: The SAVOR Study: Appetite and Physiological Responses

    Sponsor: Singapore Institute of Food and Biotechnology Innovation. Phase: NA. Conditions: Anorexia of Aging, Malnutrition or Risk of Malnutrition

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07357883: Effect of Topical Argan Oil on Healing After Laser Depigmentation.

    Sponsor: Ghada Adayil. Phase: NA. Conditions: Gingival Hyperpigmentation, Laser Depigmentation, Topical Argan Oil, Postoperative Gingival Healing

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05966883: SpermQT Prospective Observational Trial

    Sponsor: Inherent Biosciences. Phase: . Conditions: Male Infertility

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05488483: A Study of Tumor Imaging With Multispectral Optoacoustic Tomography

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Breast Cancer, Melanoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07625241: CST+MST Intervention on People Living With Mild-to-moderate Dementia

    Sponsor: Istituto Superiore di Sanità. Phase: NA. Conditions: Dementia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07412483: A Controlled Human Infection Model of Dengue

    Sponsor: Tan Tock Seng Hospital. Phase: NA. Conditions: Dengue

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07297615: 3D Liver Volumetry

    Sponsor: Medical University of Graz. Phase: NA. Conditions: Liver Surgery, Liver Cancer, Surgical Planning, Liver, Volumetric Analysis, 3D-reconstruction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05624125: BEETroot Juice to Reverse Functional Impairment in PAD

    Sponsor: Northwestern University. Phase: NA. Conditions: Peripheral Artery Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07354776: Effect of Isometric Neck Exercises on Cervicogenic Headache, Cortisol, and BDNF in Adolescents With Smartphone Addiction

    Sponsor: Khyber Medical University Peshawar. Phase: NA. Conditions: Cervicogenic Headache, Sleep Disturbance, Stress

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05731076: Self-Management Support for Lung Cancer Patients With Cachexia

    Sponsor: Changhua Christian Hospital. Phase: NA. Conditions: Cachexia-Anorexia Syndrome, Lung Neoplasm Malignant

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07557576: Effect of Opioid-Free vs Opioid-Based Anesthesia on Postoperative Pain and Emergence Agitation in Children Undergoing Cleft Surgery

    Sponsor: Iva Smiljanić. Phase: NA. Conditions: Cleft Lip Palate, Orofacial Cleft, Agitation, Emergence, Analgesia Assessment, Analgesia, Pediatric

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07320040: Evaluation of Emotion-related Salivary Molecular Biomarkers

    Sponsor: Sys2Diag. Phase: . Conditions: Emotion

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05754840: CANnabinoids in Pediatric ONCology

    Sponsor: University of Manitoba. Phase: PHASE1. Conditions: Childhood Cancer, Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05422040: Dry Needlig Vesus Tecartherapy in Low-back Pain Treatment

    Sponsor: University of Alcala. Phase: NA. Conditions: Low Back Pain

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07155668: A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

    Sponsor: Viridian Therapeutics, Inc.. Phase: PHASE3. Conditions: Thyroid Eye Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07633574: Additive vs Subtractive Manufacturing for Endocrown Fabrication: A 24-Month RCT

    Sponsor: Cairo University. Phase: NA. Conditions: Tooth, Nonvital, Dental Restoration, Endodontically Treated Teeth

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05352074: STOPS Trial: Total vs Subtotal Colectomy for Slow Transit Constipation

    Sponsor: Third Military Medical University. Phase: NA. Conditions: Slow Transit Constipation, Surgery

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07322874: Menstrual Cycle and Exercise-induced Muscle Damage

    Sponsor: Chariklia K. Deli. Phase: NA. Conditions: Menstrual Cycle Phase

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06806618: HAE Burden and Crisis Management

    Sponsor: University Hospital, Grenoble. Phase: . Conditions: Hereditary Angioedema (HAE)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06795360: Weight Changes After Incretin-mimetics

    Sponsor: Medical College of Wisconsin. Phase: NA. Conditions: Obesity and Obesity-related Medical Conditions

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07494110: Aurora: AI-Based Narrative Intervention to Support Emotional Well-Being in Clinical and Non-Clinical Populations

    Sponsor: Universitat Autonoma de Barcelona. Phase: NA. Conditions: Institutionalization, Elderly, Mental Health, Wellbeing, Aging

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07134920: Norethindrone Impact on Receptiva Outcomes

    Sponsor: Inception Fertility Research Institute, LLC. Phase: . Conditions: Infertility (IVF Patients), Infertility Female

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05718882: Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC

    Sponsor: RenJi Hospital. Phase: NA. Conditions: Liver Cancer, Hepatocellular Carcinoma, Resistant Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT00777582: Phase I Comparative Bioavailability Study

    Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Solid Tumors

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07442682: Characterisation of a Population of Adults Suffering From Cystic Fibrosis in a Belgian Reference Center

    Sponsor: Erasme University Hospital. Phase: . Conditions: Quality of Lifte, Cystic Fibrosis (CF), Diabetes

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT01580982: Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer

    Sponsor: University of Colorado, Denver. Phase: . Conditions: Lung Neoplasms

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07534059: Impact of Eating Disorders

    Sponsor: University Hospital, Rouen. Phase: . Conditions: Eating Disorders in Adolescence

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06477159: Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency

    Sponsor: Ohio State University. Phase: PHASE4. Conditions: Exocrine Pancreatic Insufficiency

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06385379: Guo's Aortic Arch Reconstruction: A Multicenter, Prospective Study of the Novel WeFlow-Tribranch System (GENIUS Study)

    Sponsor: Hangzhou Endonom Medtech Co., Ltd.. Phase: NA. Conditions: Aortic Arch Aneurysm

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06528080: A Clinical Study for the Treatment of Pediatric and Adolescent Patients With Type 1 Gaucher Disease

    Sponsor: Shanghai Jiao Tong University School of Medicine. Phase: EARLY_PHASE1. Conditions: Gaucher Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07542379: The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer

    Sponsor: FindCure Biosciences (ZhongShan) Co., Ltd.. Phase: EARLY_PHASE1. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06295796: A Study of MK-8527 in Participants With Moderate and Severe Renal Impairment (MK-8527-008)

    Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE1. Conditions: Renal Impairment

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07466862: Personalized Cooking and Nutrition Guidance and Physical Activities Program to Reduce Muscle Loss in Advanced Cancer

    Sponsor: Gali Perel. Phase: NA. Conditions: Cancer, Sarcopenia, Muscle Mass Loss

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06446427: The Effect of Acute High Altitude Exposure on Rescuer Performance and Patient Care

    Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: NA. Conditions: High Altitude, Hypobaric Hypoxia, Risk Reduction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05275686: Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)

    Sponsor: Cedars-Sinai Medical Center. Phase: PHASE2. Conditions: Eustachian Tube Dysfunction

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05380570: Epidemiological Study of Korean Radiation Workers

    Sponsor: Korea Institute of Radiological & Medical Sciences. Phase: . Conditions: Occupational Exposure to Radiation, Neoplasms, Radiation-Induced, Leukemia, Radiation-Induced, Radiation Effects

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07496970: Bilateral Cervical Plexus Block for Postoperative Pain After Thyroidectomy

    Sponsor: University of Gaziantep. Phase: NA. Conditions: Postoperative Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06884670: Assessment of Efficacy and Safety of PD-1 Monoclonal Antibody Combined With IL-2 and CapeOX in Neoadjuvant Therapy for Locally Advanced Rectal Cancer Prior to Surgery: A Prospective, Multi-center, Randomized Controlled Study

    Sponsor: The First Affiliated Hospital with Nanjing Medical University. Phase: PHASE2. Conditions: Rectal Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07015970: Real-life Follow-up of the Physical Activity in Type 1 Diabetes Participants Equipped With an Insulin Pump With Hybrid Closed Loop

    Sponsor: ISIS Diabete Service. Phase: . Conditions: Diabetes Mellitus Type 1, Glucose Metabolism Disorder, Glycemic Control for Diabetes Mellitus, Fear of Hypoglycemia, Treatment Satisfaction, Quality of Life, Hypoglycaemia

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT04243473: Biopsy Collection for Men Undergoing Brachytherapy for Prostate Cancer

    Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Phase: . Conditions: Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07550673: Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis(UPRISE)

    Sponsor: Xijing Hospital of Digestive Diseases. Phase: PHASE4. Conditions: Acute Severe Ulcerative Colitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07355673: The Influence of Isolation Techniques in Gingival Irritation During an In-office Bleaching

    Sponsor: University of Santiago de Compostela. Phase: NA. Conditions: Gingival Irritation

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07608341: Influence of Probiotics on Early Gut Microbial Colonization

    Sponsor: BioGaia AB. Phase: NA. Conditions: C-Section

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05234554: The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis

    Sponsor: Aldeyra Therapeutics, Inc.. Phase: PHASE3. Conditions: Allergic Conjunctivitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02771405: Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCC

    Sponsor: National Hepatology & Tropical Medicine Research Institute. Phase: PHASE3. Conditions: Hepatitis C, Chronic, Hepatocellular Carcinoma

    full page →ctgov ↗
    ← prev
    page 63 of 94
    next →